TRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY (TRIAL) Trademark

Trademark Overview

On Tuesday, August 27, 2024, a trademark application was filed for TRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY (TRIAL) with the United States Patent and Trademark Office. The USPTO has given the TRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY (TRIAL) trademark a serial number of 98719839. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, April 8, 2026. This trademark is owned by Northwell Health, Inc.. The TRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY (TRIAL) trademark is filed in the Insurance & Financial Services category with the following description:

Financial investment in the field of medical and healthcare companies
translational research investigators accelerator and laboratory (trial)

General Information

Serial Number98719839
Word MarkTRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY (TRIAL)
Filing DateTuesday, August 27, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, April 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements

NOT AVAILABLE"TRANSLATIONAL RESEARCH INVESTIGATORS ACCELERATOR AND LABORATORY"
Goods and ServicesFinancial investment in the field of medical and healthcare companies

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNorthwell Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Hyde Park, NY 11042
US
Party NameNorthwell Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Hyde Park, NY 11042
US

Trademark Events

Event DateEvent Description
Tuesday, August 27, 2024NEW APPLICATION ENTERED
Saturday, March 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 16, 2025ASSIGNED TO EXAMINER
Sunday, March 30, 2025EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sunday, March 30, 2025COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sunday, March 30, 2025EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sunday, March 30, 2025NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, April 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 7, 2025FINAL REFUSAL WRITTEN
Monday, July 7, 2025FINAL REFUSAL E-MAILED
Monday, July 7, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 30, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 28, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2026SOU EXTENSION 1 FILED
Wednesday, April 8, 2026SOU EXTENSION 1 GRANTED
Wednesday, April 8, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

laboratory trial accelerator investigators research translational healthcare companies medical field investment financial